Seoul Pharma Co. Ltd (018680) — Strategic Asset Allocation Index
Seoul Pharma Co. Ltd (018680) has a Strategic Asset Allocation Index of 83.5% as of March 2025. Strategic assets (PP&E of ₩33.40 Billion plus long-term investments of ₩-) total ₩33.40 Billion, measured against net assets of ₩40.01 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 018680 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Seoul Pharma Co. Ltd Strategic Asset Allocation Index (2012–2024)
This chart shows how Seoul Pharma Co. Ltd's Strategic Asset Allocation Index has evolved across 13 annual periods from 2012 to 2024. As of March 2025, the index stands at 83.5%, representing strategic assets of ₩33.40 Billion against net assets of ₩40.01 Billion KRW. See 018680 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Seoul Pharma Co. Ltd (2012–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Seoul Pharma Co. Ltd from 2012 to 2024, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Seoul Pharma Co. Ltd (018680) total market value.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 84.3% | ₩33.86 Billion | ₩33.86 Billion | ₩- | ₩40.17 Billion | ▲ +3.0 pp |
| 2023 | 81.2% | ₩31.33 Billion | ₩31.33 Billion | ₩- | ₩38.56 Billion | ▼ -5.4 pp |
| 2022 | 86.6% | ₩30.68 Billion | ₩30.68 Billion | ₩- | ₩35.42 Billion | ▼ -93.0 pp |
| 2021 | 179.6% | ₩34.05 Billion | ₩34.05 Billion | ₩- | ₩18.96 Billion | ▲ +56.7 pp |
| 2020 | 123.0% | ₩35.48 Billion | ₩35.48 Billion | ₩- | ₩28.85 Billion | ▼ -22.6 pp |
| 2019 | 145.5% | ₩41.40 Billion | ₩41.40 Billion | ₩- | ₩28.45 Billion | ▲ +62.8 pp |
| 2018 | 82.7% | ₩41.60 Billion | ₩41.28 Billion | ₩319.53 Million | ₩50.31 Billion | ▲ +2.8 pp |
| 2017 | 79.9% | ₩43.04 Billion | ₩42.76 Billion | ₩278.90 Million | ₩53.86 Billion | ▼ -43.6 pp |
| 2016 | 123.5% | ₩51.97 Billion | ₩51.43 Billion | ₩539.40 Million | ₩42.07 Billion | ▼ -19.7 pp |
| 2015 | 143.2% | ₩48.02 Billion | ₩47.52 Billion | ₩493.99 Million | ₩33.53 Billion | ▼ -12.2 pp |
| 2014 | 155.4% | ₩48.32 Billion | ₩47.86 Billion | ₩456.88 Million | ₩31.10 Billion | ▲ +154.1 pp |
| 2013 | 1.3% | ₩421.00 Million | ₩- | ₩421.00 Million | ₩32.25 Billion | ▼ -0.2 pp |
| 2012 | 1.5% | ₩391.00 Million | ₩- | ₩391.00 Million | ₩25.38 Billion | — |